Table 3.

Association between the CTI and CVD mortality according to gender

	Died/participants	Model 1	Model 2	Model 3
Male
CVD mortality	210/4216
Q1	36/1016	1 (referent)	1 (referent)	1 (referent)
Q2	59/1129	1.20 (0.78–1.84)	1.21 (0.80–1.83)	1.68 (1.06–2.39)*
Q3	63/1055	1.31 (0.84–2.03)	1.39 (0.92–2.09)	2.13 (1.37–3.06)**
Q4	52/1016	1.42 (0.86–2.34)	1.63 (1.06–2.50)*	2.28 (1.47–3.46)**
All-cause mortality	656/4216
Q1	116/1016	1 (referent)	1 (referent)	1 (referent)
Q2	178/1129	1.18 (0.93–1.50)	1.13 (0.90–1.43)	1.47 (1.15–2.81)**
Q3	194/1055	1.38 (1.07–1.77)*	1.32 (1.05–1.67)*	1.79 (1.08–2.38)**
Q4	168/1016	1.60 (1.21–2.12)**	1.61 (1.27–2.05)**	2.21 (2.76–4.89)**
Total-CVD	555/4216
Q1	90/1016	1 (referent)	1 (referent)	1 (referent)
Q2	140/1129	1.03 (0.74–1.43)	1.11 (0.82–1.51)	1.43 (1.06–1.91)**
Q3	138/1055	0.80 (0.57–1.12)	1.01 (0.74–1.37)	1.65 (1.15–2.01)**
Q4	187/1016	1.01 (0.71–1.45)	1.71 (1.27–2.29)**	2.41 (1.80–3.05)**
Female
CVD mortality	150/4463
Q1	27/1154	1 (referent)	1 (referent)	1 (referent)
Q2	32/1041	0.71 (0.41–1.20)	0.76 (0.46–1.27)	1.58 (0.87–2.45)
Q3	45/1115	1.01 (0.60–1.72)	1.03 (0.64–1.66)	1.96 (1.21–3.12)**
Q4	46/1153	1.30 (0.73–2.33)	1.56 (0.97–2.52)	2.44 (1.53–3.94)**
All-cause mortality	496/4463
Q1	89/1154	1 (referent)	1 (referent)	1 (referent)
Q2	135/1041	1.02 (0.77–1.34)	1.02 (0.78–1.34)	1.79 (1.43–2.45)**
Q3	141/1115	1.03 (0.77–1.38)	1.02 (0.78–1.33)	1.82 (1.46–2.47)**
Q4	131/1153	1.25 (0.90–1.73)	1.35 (1.03–1.77)*	2.11 (1.68–2.84)**
Total-CVD	417/4463
Q1	50/1154	1 (referent)	1 (referent)	1 (referent)
Q2	90/1041	1.00 (0.67–1.49)	1.34 (0.93–1.95)	2.02 (1.42–2.93)**
Q3	109/1115	0.95 (0.64–1.42)	1.49 (1.04–2.14)*	2.36 (1.65–3.36)**
Q4	168/1153	1.24 (0.82–1.88)	2.52 (1.79–3.54)**	3.79 (2.68–5.29)**

Model 1 did not adjust for any variables. Model 2 adjusted for sex and age. Model 3 adjusted for age, sex, education, race, smoking, alcohol use,self-reported diabetes, self-reported hypertension, systolic blood pressure (SBP), BMI, HDL, LDL, and HbA1c% levels

*P < 0.05, **P < 0.01